Work ScheduleStandard (Mon-Fri) Environmental ConditionsAdherence to all Good Manufacturing Practices (GMP) Safety Standards, Cleanroom: no hair products, jewelry, makeup, nail polish, perfume, exposed piercings, facial hair etc. allowed, Cold Room/Freezers -22degreesF/-6degrees C, Loud Noises (Equipment/Machinery), Office,
Work ScheduleStandard (Mon-Fri) Environmental ConditionsAdherence to all Good Manufacturing Practices (GMP) Safety Standards, Office, Some degree of PPE (Personal Protective Equipment) required (safety glasses, gowning, gloves, lab coat, ear plugs etc.) Job Description Thermo Fisher Scientific
Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a singular purpose:
Experteer Italy is seeking a Senior Process Scientist to oversee process development and manufacturing for gene therapy programs at Chiesi Global Rare Diseases. The ideal candidate will have extensive experience in biotech, particularly in gene editing
Experteer OverviewIn this Senior Process Scientist role, you will lead process development and manufacturing oversight for gene therapy programs within Chiesi Global Rare Diseases, focusing on synthetic nucleotides and RNA-guided editing components. You will serve as
Overview Location: Ancona (Italy) Contract: Temporary Working day: Full time Sector: Pharmaceutical and biopharmaceutical Vacancies: 1 Discipline: Quality Work modality: On site Kymos Group – Pharmaprogress is a reliable Contract Research Organization part of the Kymos
Senior Analytical Scientist – LNP/RNA Analytics Location: Parma, Italy (remote/hybrid options across Europe) Business Area: R&D, Pharmacovigilance & Regulatory AffairsJob Type: Direct Employee – Permanent Responsibilities Define and lead the development plan for analytical techniques used
Experteer OverviewAs a Senior Analytical Scientist in Chiesi Global Rare Diseases, you lead analytical development for RNA and nanoparticle-based therapies, including mRNA‑LNP products. You will shape the control strategy and act as SME for method development,